Glaxosmithkline Pharmaceuticals Ltd Share Price
Last Updated Date: 21 Sept 2026
₹2,860.60
+8.75 (+0.31%)
As of 21 Sept 2026, Glaxosmithkline Pharmaceuticals Ltd share price is ₹2,860.60. The stock opened at ₹2,860.60 and had closed at ₹2,851.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹2,088.00 and a high of ₹3,121.10. In terms of performance, Glaxosmithkline Pharmaceuticals Ltd share price has increased by 19.78% over the past six months and has increased by 3.29% over the last year.
GLAXO Stock Price Chart
Glaxosmithkline Pharmaceuticals Ltd Overview
Market cap₹48,312 Crs
Volume2,159
Prev. Close₹2,851.85
Year range₹2,088.00 - ₹3,121.10
ISININE159A01016
About GLAXO
GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.
Glaxosmithkline Pharmaceuticals Ltd Historical Performance
1 Month Return-1.09%
6 Month Return17.11%
3 Year Return79.27%
3 Month Return25.81%
1 Year Return3.73%
5 Year Return89.97%
Glaxosmithkline Pharmaceuticals Ltd Fundamentals
ROCE(TTM)60.63%
P/E Ratio (TTM)45.56
P/B Ratio21.56
Debt to Equity0.01
ROE45.15%
EPS (TTM)62.48
Dividend Yield2.00%
Book Value132.30
Profit Margin27.07%
Operating Margin32.63%
Glaxosmithkline Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 3,932.76 | 3,866.05 | 3,530.73 | 3,317.86 | 3,293.73 |
| EBITDA | 1,445.40 | 1,316.54 | 880.52 | 899.96 | 843.63 |
| Net Profit | 1,011.82 | 919.06 | 584.69 | 607.75 | 1,690.53 |
| EPS | 59.59 | 54.01 | 40.83 | 35.88 | 99.79 |
Glaxosmithkline Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 2,804.87 |
| Resistance 1 (R1) | 2,894.42 |
| Pivot Point | 2,847.43 |
Glaxosmithkline Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 29-May-2026 | 13-May-2026 | 29-May-2026 | Final | ₹57.00 |
| 30-May-2025 | 13-May-2025 | 30-May-2025 | Final | ₹42.00 |
| 07-Nov-2024 | 29-Oct-2024 | 07-Nov-2024 | Special | ₹12.00 |
| 31-May-2024 | 17-May-2024 | 31-May-2024 | Final | ₹32.00 |
| 30-Jun-2023 | 17-May-2023 | 30-Jun-2023 | Final | ₹32.00 |
GLAXO Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Renu S. Karnad | Chairman |
| Bhushan Akshikar | Managing Director |
| Manu Anand | Non Executive Independent Director |
Glaxosmithkline Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,876.20+2.12% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,396.50+0.23% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,971.50+2.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Glaxosmithkline Pharmaceuticals Ltd today is ₹2,860.60 on NSE and ₹2,860.60 on BSE.
- The 52-week high of Glaxosmithkline Pharmaceuticals Ltd is ₹3,121.10, while the 52-week low is ₹2,088.00.
- The current market capitalisation of Glaxosmithkline Pharmaceuticals Ltd is approximately ₹48,312 crore.
- The P/E (Price-to-Earnings) ratio of Glaxosmithkline Pharmaceuticals Ltd is 41.19. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Glaxosmithkline Pharmaceuticals Ltd is 24.63. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Glaxosmithkline Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for GLAXO on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Glaxosmithkline Pharmaceuticals Ltd has delivered a return of approximately 79.27%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.00% promoters, -0.08% FIIs, 7.80% DIIs, and 10.21% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
